News
Boston Scientific will face more benign competition than previously feared when it comes to pulsed field ablation, according ...
Hosted on MSN5mon
Boston Sci stock falls 4% amid FARAPULSE study updateBoston Scientific (NYSE:BSX) shares were down 5% in morning trading Wednesday following news that the company has paused a study for its new FARAPULSE Pulse Field Ablation system due to unforeseen ...
Boston Scientific’s pulsed field ablation catheter, Farapulse, was noninferior to Medtronic’s Arctic Front cryoballoon in a randomized trial, researchers found in a study published in The New ...
We came across a bullish thesis on Boston Scientific Corporation (BSX) on Substack by Magnus Ofstad. In this article, we will ...
Pulsed field ablation using Boston Scientific Corp.’s Farapulse system was non-inferior and even superior, slightly, to Medtronic plc’s Artic Front Advance cardiac cryoablation system in treating ...
Recent acquisitions are also seen as adding to Boston Scientific’s growth story. Bolt Medical’s new device for treating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results